Showing results (2281-2290 of 2,945) with videos related to

Sort By:
Pageof 295
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugatesA Harrison, C A Walker, D Parker, et al.
Nature Communications|December 16, 2020
A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebiteLaura-Oana Albulescu, Chunfang Xie, Stuart Ainsworth, et al.
The Annals of Thoracic Surgery|August 1, 1997
Pulmonary valve replacement late after repair of tetralogy of FallotI M Yemets, W G Williams, G D Webb, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 22, 2023
Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activityWilliam A Stocker, James A Howard, Shreya Maskey, et al.
Hepatology (Baltimore, Md.)|December 19, 2023
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitisVlad Ratziu, Sven Francque, Cynthia A Behling, et al.
Scientific Reports|June 11, 2023
Identification of novel p-cresol inhibitors that reduce Clostridioides difficile's ability to compete with species of the gut microbiomeMark A Harrison, Rebecca J Farthing, Nyasha Allen, et al.
Plos One|September 8, 2018
Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trialStephen A Harrison, Andrea Dennis, Martine M Fiore, et al.
Psychiatry and Clinical Neurosciences|May 3, 2007
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and BrazilPhil Lee, Liang Shu, Xiufeng Xu, et al.
The Journal of Biological Chemistry|September 25, 1999
Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholinesG K Marathe, S S Davies, K A Harrison, et al.
Vaccine|January 8, 2026
Heterologous vs. homologous vaccine regimens: Sulfated lactosyl archaeol (SLA) archaeosome-adjuvanted SARS-CoV-2 spike protein boost following an mRNA/LNP prime induces robust and balanced immune responsesTyler M Renner, Gerard Agbayani, Hiva Azizi, et al.
Pageof 295